IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin

European Journal of Immunology

Volumn 36, Issue 1, 2006, Pages 216-223

  Mensah Brown, Eric P K ^a   Shahin, Allen ^a   Al Shamisi, Mariam ^a   Wei, Xiaoging ^b   Lukic, Miodrag L ^a,c  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Diabetes; IFN ; IL 17; IL 23

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INSULIN; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 23; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DAMAGE; CELL INFILTRATION; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETOGENESIS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; STREPTOZOCIN DIABETES; WEIGHT REDUCTION;

EID: 30944455075     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535325     Document Type: Article

References (47)

1. Weiss, R. B., Streptozotocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat. Rep. 1982. 66: 427-438.
2. Ohly, P., Dohle, C., Abel, J., Seissler, J. and Gleichmann, H., Zinc sulfate induces metallothionein in pancreatic islet of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 2000. 43: 1020-1030.
3. Friesen, N. T. E., Buchau, A. S., Schott-Ohly, P., Lgssiar, A. and Gleichmann, H., Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin. Diabetologia 2004. 47: 676-685.
4. Chol, S. E., Noh, H. L, Kim, H. M., Yoon, J. W. and Kang, Y., Streptozotocin upregulates GAD67 expression in MIN6N8a mouse beta cells. J. Autommun. 2002. 19: 1-8.
5. Jun, H. S., Chung, H. Y., Han, J., Kim, A., Yoo, S. S., Sherwin, R. S. and Yoon, J. W., Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expression glutamic acid decarboxylase. Diabetologia 2002. 45: 668-676.
6. 500-585. J. Immunol. 2005. 174: 4516-4524.
7. Elias, D., Prigozin, H., Polak, N., Rapoport, M., Lohse, A. W. and Cohen, I. R., Autommune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes 1994. 43: 992-998.
8. Lukic, M. L., Mensah-Brown, E., Wei, X., Shahin, A., Liew, F. Y., Lack of the mediators of innate immunity attenuates the development of autoimmune diabetes in mice. J. Autoimmun. 2003. 21: 239-246.
9. Mensah-Brown, E. P., Stosic-Grujicic, S., Maksimovic, D., Jasima, A., Shahin, A. and Lukic, M. L., Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes. Mol. Immunol. 2002. 38: 941-946.
10. Stosic-Grujicic, S., Maksimovic, D., Badovinac, V., Samardzic, T., Trajkovic, V., Lukic, M. L. and Mostarica-Stojkovic, M., Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production. J. Autoimmun. 2001. 16: 47-58.
11. Lamhamedi-Cherradi, S. E., Zheng, S., Tisch, R. M. and Chen, Y. H., Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes. Diabetes 2003. 52: 2274-2278.
12. Nicoletti, F., Di Marco, R., Papaccio, G., Conget, I, Gomis, R., Bernadini, R., Sims, JE. et al., Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur. J. Immunol. 2003. 33: 2278-2286.
13. Pechhold, K., Patterson, N. B., Blum, C., Fleischacker, C. L., Boehm, B. O. and Harlan, D. M., Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent. J. Immunol. 2001. 166: 2531-2539.
14. Trinchieri, G., Pflanz, S. and Kastelein, R. A., The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003. 19: 641-644.
15. Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003. 3: 133-146.
16. Sonobe, Y., Yawata, I., Kawanokuchi, J., Takeuchi, H., Mizuno, T. and Suzumura, A., Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 2005. 1040: 202-207.
17. Homo-Delarche, F. and Drexhage, H. A., Immune cells, pancrease development, regeneration and type 1 diabetes. Trends Immunol. 2004. 25: 222-229.
18. Kolb, H., Burkart, V., Appels, B., Hanenberg, H., Kantwerk-Funke, G., Kiesel, U. et al., Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J. Autoimmun. 1990 Suppl. 1: 117-120.
19. Lukic, M. L., Stosic-Grujicic, S., and Shahin, A., Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev. Immunol. 1998. 6: 119-128.
20. Haase, C., Skak, K., Michelsen, B. K. and Markholst, H., Local activation of dendritic cells leads to insulitis and development of insulin-dependent diabetes in transgenic mice expression CD154 on the pancreatic β-cells. Diabetes 2004. 53: 2588-2595.
21. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 2004. 199: 1467-1477.
22. Krakowski, M: and Owens, T., Inteferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 1996. 26: 1641-1646.
23. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744-748.
24. Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D. et al., Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003. 198: 1951-1957.
25. Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M. and Krueger, JG., Increased expression of interleukin 23 p10 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 2004. 199: 125-130.
26. Windsor, L., Morahan, G., Huang, D., McCann, V., Jones, T., James, I., Christiansen, T. and Price, P., Alleles of the IL12B 3′UTR Associate with late onset of type-1 diabetes. Hum. Immunol. 2004. 65: 1432-1436.
27. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basahm, B., Sedgwick, D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233-240.
28. Lukic, M. L., Stosic-Grujucic, S., Ostojic, N., Chan, W. L. and Liew, F. Y., Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun. 1991. 178: 913-920.
29. Mensah-Brown, E. P., Stosic-Grujicic, S., Maksimovic, D., Jasima, A., Shahin, A. and Lukic, M. L., Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes. Mol. Immunol. 2002. 38: 941-946.
30. Thomas, H. E., Darwiche, R., Corbett, J. A. and Kay, T. W., Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. Diabetes 2002. 51: 311-316.
31. Kato, Y., Miura, Y., Yamamoto, N., Ozaki, N. and Oiso, Y., Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction. Diabetologia 2003. 46: 1228-1233.
32. Kleemann, R., Rothe, H., Kolb-Bachofen, V., Xie, Q. W., Nathan, C., Martin, S. and Kolb, H., Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 1993. 328: 9-12.
33. Trembleau, S., Penna, G., Gregori, S., Giarratana, N. and Adorini, L., IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-γ-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-γ. Immunology 2003. 170: 5491-5501.
34. Eijnden, S. V., Goriely, S., De Wit, D., Willems, F. and Goldman, M., IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naïve T cells in human. Eur. J. Immunol. 2005, 35: 469-475.
35. Gran, B., Touil, T., Chu, N., Yonghai, L., Zhang, G. X. and Rostami, A. M., Role of IL-23 in experimental autoimmune encephalomyelitis: a paradoxical effect. FASEB J. 2005. 19: A 326 (Abstract 247. 5).
36. Bettelli, E. and Kuchroo, V. K., IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J. Exp. Med. 2005. 201: 169-171.
37. Jovanovic, D,V., Di Battista, J. A., Marterl-Pelletier, J., Jolicoeur, F.C., He, Y., Zhang, M., Mineau, F. et al., IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 1998. 160: 3513-3521.
38. Hill, N. and Sarvetnick, N., Cytokines: promoters and dampeners of autoimmunity. Curr. Opin. Immunol. 2002. 14: 791-797.
39. Gysemans, C. A., Pavlovic, D., Bouillon, R., Eizirik, D. L. and Mathieu, C., Dual role of interferon-gamma signaling pathway in sensitivity of pancreatic beta cells to immune destruction. Diabetologia 2001. 44: 567-574.
40. Rasschaert, J., Ladrière, L., Irbain, M., Dogusan, Z., Katabua, B., Sata, S., Akira, S. et al., Toll-like receptor 3 and STAT-1 contribute for dsRNA+IFN-γ-induced apoptosis in primary pancreatic β-cells. J. Biol. Chem. 2005. 280: 33984-33991.
41. Gysemans, C. A., Ladriere, L., Callewaert, H., Rasschaert, J., Flamez, D., Levy, D.E., Matthys, P. et al., Disruption of the γ-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of β cells. Diabetes 2005. 54: 2396-2403.
42. Miljkovic, D. and Trajkovic, V., Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev. 2004, 15: 21-32.
43. Van Bezooijen, R. L., Van Der Wee-Pals, L., Papapoulos, S. E. and Lowik, C. W., Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro. Ann. Rheum. Dis. 2002. 61: 870-876.
44. Koenders, M. I., Lubberts, E., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M. M., Kolls, J. K., Joosten, L. A. et al., Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum. 2005. 52: 975-983.
45. Happel, K. I., Dubin, P. J., Zheng, M., Ghilardi, N., Lockhart, C., Quinton, L. J., Odden, A. R. et al., Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 2005. 202: 761-769.
46. Lacy, P. E. and Kostianovsky, M., Method of isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967. 16: 35-39.
47. Lernmark, A., The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia 1974. 10: 431-438.